Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 149.37

-4.5%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Laz who wrote (377)	1/2/2008 10:57:55 AM
From: Bob Laz	of 395

Harvey - Did you see the Yahoo / RGEN message board mentioning Michael Kransavage / Forbes reference to BMY? Of course the rest is simply the posters opinion which means nothing - however - although the possibility of a buyout is slim - it still exists and with Uridine in play it sure makes a big difference offering ORENCIA and another very significant possibility for bi-polar - just what the big boys are searching for. Last regarding Uridine - the conference call for the Q mentioned the possibility of teaming up with an existing drug for bipolar / this adds value for whatever company that makes a bipolar drug to look at RGEN. Again - would love to wake up to $12-$15 per share!!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next